These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34166526)

  • 41. Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial.
    Petersen JZ; Schmidt LS; Vinberg M; Jørgensen MB; Hageman I; Ehrenreich H; Knudsen GM; Kessing LV; Miskowiak KW
    Trials; 2018 Nov; 19(1):611. PubMed ID: 30400939
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential executive functioning performance by phase of bipolar disorder.
    Ryan KA; Vederman AC; McFadden EM; Weldon AL; Kamali M; Langenecker SA; McInnis MG
    Bipolar Disord; 2012 Aug; 14(5):527-36. PubMed ID: 22834461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interaction between COMT rs5993883 and second generation antipsychotics is linked to decreases in verbal cognition and cognitive control in bipolar disorder.
    Flowers SA; Ryan KA; Lai Z; McInnis MG; Ellingrod VL
    BMC Psychol; 2016 Apr; 4():14. PubMed ID: 27039372
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolic syndrome and adverse clinical outcomes in patients with bipolar disorder.
    Bai YM; Li CT; Tsai SJ; Tu PC; Chen MH; Su TP
    BMC Psychiatry; 2016 Dec; 16(1):448. PubMed ID: 27978821
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cognitive performance and quality of life in bipolar disorder.
    Brissos S; Dias VV; Kapczinski F
    Can J Psychiatry; 2008 Aug; 53(8):517-24. PubMed ID: 18801213
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neurocognitive function in unmedicated manic and medicated euthymic pediatric bipolar patients.
    Pavuluri MN; Schenkel LS; Aryal S; Harral EM; Hill SK; Herbener ES; Sweeney JA
    Am J Psychiatry; 2006 Feb; 163(2):286-93. PubMed ID: 16449483
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Allostatic load but not medical burden predicts memory performance in late-life bipolar disorder.
    Vaccarino SR; Rajji TK; Gildengers AG; Waters SES; Butters MA; Menon M; Blumberger DM; Voineskos AN; Miranda D; Mulsant BH
    Int J Geriatr Psychiatry; 2018 Mar; 33(3):546-552. PubMed ID: 29235143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence for cognitive subgroups in bipolar disorder and the influence of subclinical depression and sleep disturbances.
    Volkert J; Kopf J; Kazmaier J; Glaser F; Zierhut KC; Schiele MA; Kittel-Schneider S; Reif A
    Eur Neuropsychopharmacol; 2015 Feb; 25(2):192-202. PubMed ID: 25156468
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cognitive dysfunction is worse among pediatric patients with bipolar disorder Type I than Type II.
    Schenkel LS; West AE; Jacobs R; Sweeney JA; Pavuluri MN
    J Child Psychol Psychiatry; 2012 Jul; 53(7):775-81. PubMed ID: 22339488
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hippocampal volume and verbal memory performance in late-stage bipolar disorder.
    Cao B; Passos IC; Mwangi B; Bauer IE; Zunta-Soares GB; Kapczinski F; Soares JC
    J Psychiatr Res; 2016 Feb; 73():102-107. PubMed ID: 26714201
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of cognitive impairment, neurological soft signs and subdepressive symptoms on functional outcome in bipolar disorder.
    Baş TÖ; Poyraz CA; Baş A; Poyraz BÇ; Tosun M
    J Affect Disord; 2015 Mar; 174():336-41. PubMed ID: 25545601
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypothalamus-pituitary-adrenal (HPA) axis parameters and neurocognitive evaluation in patients with bipolar disorder.
    Tournikioti K; Dikeos D; Alevizaki M; Michopoulos I; Ferentinos P; Porichi E; Soldatos CR; Douzenis A
    Psychiatriki; 2018; 29(3):199-208. PubMed ID: 30605424
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stability and course of neuropsychological deficits in manic and depressed bipolar patients compared to patients with Major Depression.
    Gruber S; Rathgeber K; Bräunig P; Gauggel S
    J Affect Disord; 2007 Dec; 104(1-3):61-71. PubMed ID: 17360041
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of cognitive function in bipolar disorder using the Brief Assessment of Cognition in Affective Disorders (BAC-A).
    Bauer IE; Keefe RS; Sanches M; Suchting R; Green CE; Soares JC
    J Psychiatr Res; 2015 Jan; 60():81-6. PubMed ID: 25455513
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuropsychological performance in euthymic Indian patients with bipolar disorder type I: correlation between quality of life and global functioning.
    Pattanayak RD; Sagar R; Mehta M
    Psychiatry Clin Neurosci; 2012 Dec; 66(7):553-63. PubMed ID: 23252921
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: A pilot, open-label study.
    Mansur RB; Ahmed J; Cha DS; Woldeyohannes HO; Subramaniapillai M; Lovshin J; Lee JG; Lee JH; Brietzke E; Reininghaus EZ; Sim K; Vinberg M; Rasgon N; Hajek T; McIntyre RS
    J Affect Disord; 2017 Jan; 207():114-120. PubMed ID: 27721184
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neurocognitive impairment and psychosis in bipolar I disorder during early remission from an acute episode of mood disturbance.
    Levy B; Weiss RD
    J Clin Psychiatry; 2010 Feb; 71(2):201-6. PubMed ID: 19925749
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictors of psychotropic medication adherence among HIV+ individuals living with bipolar disorder.
    Casaletto KB; Kwan S; Montoya JL; Obermeit LC; Gouaux B; Poquette A; Heaton RK; Atkinson JH; Moore DJ;
    Int J Psychiatry Med; 2016; 51(1):69-83. PubMed ID: 26681237
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neurocognitive features in clinical subgroups of bipolar disorder: A meta-analysis.
    Bora E
    J Affect Disord; 2018 Mar; 229():125-134. PubMed ID: 29306692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.